Sell MRVL $185 CSP into elevated IV — ~56% annualized at ~10% margin of safety
Collect rich premium on MRVL via a short-dated CSP struck ~10% OTM, capitalizing on elevated ATM IV while maintaining a safety buffer above the 50-day moving average.
Trade Structure
| Strike | $185.00 |
| Expiry | 2026-06-26 |
| Premium Target | $8.88 |
| Annualized Yield | 67.4% |
| If Assigned (cost basis) | $176.12 |
Thesis
IV rank context — ATM implied volatility sits at 83-87%, placing the stock in rich premium territory driven by AI custom-silicon demand and a massive YoY rerating. This elevated volatility environment provides a favorable risk/reward for selling premium.
Strike rationale — The $185 strike offers ~9.8% downside buffer from the $205 spot price. While not below the 200DMA, it sits well above the 50DMA (~$147), providing a reasonable margin of safety against normal pullbacks while capturing a 56.7% annualized yield.
Risk: assignment scenario — MRVL is trading near 52-week highs with a stretched P/E of 70.4. A sector rotation or macro shift could trigger a sharp pullback. If assigned, the $176.12 basis remains a 14% discount to current spot and 80%+ above the 200DMA, making it a manageable entry for a long-term AI infrastructure play.
Exit / management plan — Target 50% profit on the $8.88 credit for early exit. If the stock holds above $185, let expire worthless or roll to late July. If tested, roll down/out before 21 DTE to manage risk. Close entirely before the August 27 earnings report to avoid IV crush.
Entry
Exit
Risk
Bear case:
What breaks the thesis:
Performance
| Paper Position | 10 contracts (csp) |
| Capital at Risk | $185000.00 |
| Unrealized P&L | +$8,880 |
| Current Return | +4.8% |
| Current Price | $279.04 |
Sources
- Price History + MA200 (link withheld)
- Technicals RSI/MACD (link withheld)
- Fundamentals — Market Cap $179B, P/E 70/34, FCF $2.3B (link withheld)
- Next Earnings Aug 27 2026 (outside all candidate expiries) (link withheld)
- Options Chain Jun-26 / Jul-02 / Jul-17 ATM IV ~83-87% (link withheld)
- Q1 FY2027 8-K — Record revenue, raised FY2028 guidance
Pipeline trace
——PASSEducational content only. Not investment advice. The author and operator may or may not hold positions. Verify all numbers independently before acting. Full disclosures.